Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
|Variable†||OR (95% CI)||p value|
|Pretransplant ESBLE fecal carriage||18.4 (7.1–47.5)||<0.0001|
|MELD score >25||2.9 (1.4–6.2)||0.0053|
|Return to surgery||2.7 (1.3–5.9)||0.011|
*ESBLE, extended-spectrum β-lactamase-producing Enterobacteriaceae; OR, odds ratio; MELD, Model for End-stage Liver Disease.
†Other factors initially in the model were hepatocellular carcinoma, acute liver failure, pretransplant ICU stay >48h, hospital stay >10 d in the 6 mo before transplant, spontaneous bacterial peritonitis in the 6 mo before transplant, red blood cells transfused, and posttransplant acute renal failure.
- Page created: May 17, 2012
- Page last updated: May 17, 2012
- Page last reviewed: May 17, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)